UiPath (NYSE:PATH) PT Raised to $25.00

UiPath (NYSE:PATH) had its price objective hoisted by equities researchers at Wells Fargo & Company from $24.00 to $25.00 in a research report issued to clients and investors on Thursday, Benzinga reports. The firm currently has an “equal weight” rating on the healthcare company’s stock. Wells Fargo & Company‘s target price points to a potential upside of 8.39% from the company’s current price.

A number of other equities analysts have also issued reports on PATH. Barclays boosted their target price on shares of UiPath from $23.00 to $25.00 and gave the stock an “equal weight” rating in a research report on Friday. JPMorgan Chase & Co. upgraded shares of UiPath from a “neutral” rating to an “overweight” rating and boosted their target price for the company from $22.00 to $28.00 in a research note on Thursday. DA Davidson boosted their target price on shares of UiPath from $20.00 to $24.00 and gave the company a “neutral” rating in a research note on Thursday. William Blair initiated coverage on shares of UiPath in a research report on Tuesday, January 2nd. They set an “outperform” rating on the stock. Finally, BMO Capital Markets boosted their price objective on UiPath from $24.00 to $28.00 and gave the stock a “market perform” rating in a report on Thursday. Nine research analysts have rated the stock with a hold rating and seven have issued a buy rating to the stock. According to MarketBeat, UiPath has an average rating of “Hold” and an average price target of $27.13.

UiPath Price Performance

PATH traded up $0.32 during midday trading on Thursday, hitting $23.07. 9,842,354 shares of the company’s stock traded hands, compared to its average volume of 10,074,664. The company has a market cap of $13.06 billion, a PE ratio of -135.46 and a beta of 0.97. The stock’s fifty day simple moving average is $23.52 and its 200-day simple moving average is $20.70. UiPath has a one year low of $12.38 and a one year high of $27.87.

Insider Buying and Selling

In related news, CFO Ashim Gupta sold 125,000 shares of the firm’s stock in a transaction dated Thursday, January 4th. The stock was sold at an average price of $22.59, for a total value of $2,823,750.00. Following the sale, the chief financial officer now directly owns 858,148 shares of the company’s stock, valued at $19,385,563.32. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. In other news, CFO Ashim Gupta sold 125,000 shares of UiPath stock in a transaction dated Thursday, January 4th. The stock was sold at an average price of $22.59, for a total transaction of $2,823,750.00. Following the sale, the chief financial officer now directly owns 858,148 shares of the company’s stock, valued at $19,385,563.32. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Rich Wong sold 200,000 shares of UiPath stock in a transaction dated Monday, January 8th. The shares were sold at an average price of $23.12, for a total value of $4,624,000.00. Following the sale, the director now directly owns 429,418 shares in the company, valued at $9,928,144.16. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 411,000 shares of company stock worth $9,418,670. Company insiders own 31.03% of the company’s stock.

Institutional Investors Weigh In On UiPath

A number of hedge funds have recently added to or reduced their stakes in the business. Vanguard Group Inc. increased its holdings in UiPath by 0.9% in the fourth quarter. Vanguard Group Inc. now owns 38,084,858 shares of the healthcare company’s stock worth $946,028,000 after purchasing an additional 334,085 shares in the last quarter. Gerber LLC bought a new stake in shares of UiPath during the fourth quarter valued at approximately $455,000. Sierra Summit Advisors LLC bought a new stake in shares of UiPath during the fourth quarter valued at approximately $5,897,000. GSA Capital Partners LLP bought a new stake in shares of UiPath during the fourth quarter valued at approximately $259,000. Finally, Public Employees Retirement System of Ohio increased its holdings in shares of UiPath by 4.1% during the fourth quarter. Public Employees Retirement System of Ohio now owns 159,357 shares of the healthcare company’s stock valued at $3,958,000 after acquiring an additional 6,335 shares in the last quarter. 59.04% of the stock is currently owned by institutional investors.

About UiPath

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, and Japan. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.